Contraceptive options for women with metabolic syndrome

2010, U S. Medical Eligibility Criteria for Contraceptive Use, 2010, MMWR Recomm Rep, 59, 1 Flegal, 2010, Prevalence and trends in obesity among US adults, 1999-2008, JAMA, 303, 235, 10.1001/jama.2009.2014 Alberti, 2005, The metabolic syndrome—a new worldwide definition, Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8 2001, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Balkau, 1999, Comment on the provisional report from the WHO consultation, Diabet Med, 16, 442, 10.1046/j.1464-5491.1999.00059.x Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Brunner Huber, 2007, Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth, Am J Epidemiol, 166, 1306, 10.1093/aje/kwm221 Kaneshiro, 2008, The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth, Contraception, 77, 234, 10.1016/j.contraception.2007.10.012 Finer, 2006, Disparities in rates of unintended pregnancy in the United States, 1994 and 2001, Perspect Sex Reprod Health, 38, 90, 10.1363/3809006 Vahratian, 2009, Family-planning practices among women with diabetes and overweight and obese women in the 2002 National Survey For Family Growth, Diabetes Care, 32, 1026, 10.2337/dc08-2105 Grimes, 2005, Family planning for obese women: challenges and opportunities, Contraception, 72, 1, 10.1016/j.contraception.2005.04.002 Higginbotham, 2009, Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091, Contraception, 80, 583, 10.1016/j.contraception.2009.08.001 Abernethy, 1986, Drug disposition in obese humans, Clin Pharmacokinet, 11, 199, 10.2165/00003088-198611030-00002 Speerhas, 1995, Drug metabolism in malnutrition and obesity: clinical concerns, Cleve Clin J Med, 62, 73, 10.3949/ccjm.62.1.73 O'Connell, 2005, Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive, Contraception, 72, 323, 10.1016/j.contraception.2005.05.008 Gallo, 2004, Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials, Obstet Gynecol, 103, 359, 10.1097/01.AOG.0000107298.29343.6a Funk, 2005, Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel, Contraception, 71, 319, 10.1016/j.contraception.2004.11.007 Kiriwat, 1998, A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand, Eur J Contracept Reprod Health Care, 3, 85, 10.3109/13625189809051409 Hassan, 2003, Weight variation in a cohort of women using copper IUD for contraception, Contraception, 68, 27, 10.1016/S0010-7824(03)00079-9 Linne, 2003, Weight development over time in parous women—the SPAWN study—15 years follow-up, Int J Obes Relat Metab Disord, 27, 1516, 10.1038/sj.ijo.0802441 Ronnerdag, 1999, Health effects of long-term use of the intrauterine levonorgestrel-releasing system, Acta Obstet Gynecol Scand, 78, 716, 10.1080/j.1600-0412.1999.780810.x Bahamondes, 2001, Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years, Contraception, 64, 223, 10.1016/S0010-7824(01)00255-4 Mangan, 2002, Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate, J Pediatr Adolesc Gynecol, 15, 79, 10.1016/S1083-3188(01)00147-4 Bonny, 2006, Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method, Arch Pediatr Adolesc Med, 160, 40, 10.1001/archpedi.160.1.40 Ramsay, 2006, ABC of obesity, BMJ, 333, 1159, 10.1136/bmj.39049.439444.DE1 Crane, 1997, Association between pre-pregnancy obesity and the risk of cesarean delivery, Obstet Gynecol, 89, 213, 10.1016/S0029-7844(96)00449-8 Perlow, 1994, Massive maternal obesity and perioperative cesarean morbidity, Am J Obstet Gynecol, 170, 560, 10.1016/S0002-9378(94)70227-6 Rosenberg, 2003, Prepregnancy weight and adverse perinatal outcomes in an ethnically diverse population, Obstet Gynecol, 102, 1022, 10.1016/j.obstetgynecol.2003.07.005 Sebire, 2001, Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London, Int J Obes Relat Metab Disord, 25, 1175, 10.1038/sj.ijo.0801670 Jensen, 2003, Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women, Am J Obstet Gynecol, 189, 239, 10.1067/mob.2003.441 Sheiner, 2004, Maternal obesity as an independent risk factor for caesarean delivery, Paediatr Perinat Epidemiol, 18, 196, 10.1111/j.1365-3016.2004.00557.x Perkins, 2007, Perspectives in gestational diabetes mellitus: a review of screening, diagnosis, and treatment, Clin Diabetes, 25, 57, 10.2337/diaclin.25.2.57 Becerra, 1990, Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study, Pediatrics, 85, 1 de Valk, 2006, Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis from the Netherlands, Rev Diabet Stud, 3, 134, 10.1900/RDS.2006.3.134 Fuhrmann, 1983, Prevention of congenital malformations in infants of insulin-dependent diabetic mothers, Diabetes Care, 6, 219, 10.2337/diacare.6.3.219 Alam, 2006, Neonatal complications in infants born to diabetic mothers, J Coll Physicians Surg Pak, 16, 212 Ehrenberg, 2004, The influence of obesity and diabetes on the risk of cesarean delivery, Am J Obstet Gynecol, 191, 969, 10.1016/j.ajog.2004.06.057 Landon, 1987, Neonatal morbidity in pregnancy complicated by diabetes mellitus: predictive value of maternal glycemic profiles, Am J Obstet Gynecol, 156, 1089, 10.1016/0002-9378(87)90116-5 Lyus, 2010, Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women, Contraception, 81, 367, 10.1016/j.contraception.2010.01.010 Ortiz, 2007, Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action, Contraception, 75, S16, 10.1016/j.contraception.2007.01.020 Kaunitz, 2010, Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial, Obstet Gynecol, 116, 625, 10.1097/AOG.0b013e3181ec622b 1991, Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer, Int J Cancer, 49, 186, 10.1002/ijc.2910490208 Mansour, 2004, Implications of the growing obesity epidemic on contraception and reproductive health, J Fam Plann Reprod Health Care, 30, 209, 10.1783/0000000042177027 Brinton, 1992, Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study, Am J Obstet Gynecol, 167, 1317, 10.1016/S0002-9378(11)91709-8 Curtis, 2007, Neoplasia with use of intrauterine devices, Contraception, 75, S60, 10.1016/j.contraception.2007.01.002 Jick, 1993, Oral contraceptives and endometrial cancer, Obstet Gynecol, 82, 931 1988, Endometrial cancer and combined oral contraceptives, Int J Epidemiol, 17, 263, 10.1093/ije/17.2.263 Varma, 2006, Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—a systematic enquiry and overview, Eur J Obstet Gynecol Reprod Biol, 125, 9, 10.1016/j.ejogrb.2005.10.029 Rogovskaya, 2005, Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial, Obstet Gynecol, 105, 811, 10.1097/01.AOG.0000156301.11939.56 Yen, 2010, IUDs and adolescents—an under-utilized opportunity for pregnancy prevention, J Pediatr Adolesc Gynecol, 23, 123, 10.1016/j.jpag.2009.09.004 Suhonen, 2004, Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study, Contraception, 69, 407, 10.1016/j.contraception.2003.11.008 Graesslin, 2008, The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience, Eur J Contracept Reprod Health Care, 13, 4, 10.1080/13625180801942754 Darney, 2009, Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials, Fertil Steril, 91, 1646, 10.1016/j.fertnstert.2008.02.140 Vicente, 2008, Etonogestrel implant in women with diabetes mellitus, Eur J Contracept Reprod Health Care, 13, 387, 10.1080/13625180802382604 Mosher, 2004, Use of contraception and use of family planning services in the United States: 1982-2002, Adv Data, 250, 1 Hatcher, 2004 Abdollahi, 2003, Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use, Thromb Haemost, 89, 493, 10.1055/s-0037-1613379 Nightingale, 2000, The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives, Eur J Contracept Reprod Health Care, 5, 265, 10.1080/13625180008500402 1995, results of international multicentre case-control study, Lancet, 346, 1575, 10.1016/S0140-6736(95)91926-0 Lidegaard, 2002, Oral contraceptives and venous thromboembolism: a five-year national case-control study, Contraception, 65, 187, 10.1016/S0010-7824(01)00307-9 Pomp, 2007, Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations, Br J Haematol, 139, 289, 10.1111/j.1365-2141.2007.06780.x Schwartz, 1998, Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies, Stroke, 29, 2277, 10.1161/01.STR.29.11.2277 Sidney, 1998, Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies, Circulation, 98, 1058, 10.1161/01.CIR.98.11.1058 Sidney, 2004, Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives, Contraception, 70, 3, 10.1016/j.contraception.2004.02.010 Brunner, 2005, The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth, Ann Epidemiol, 15, 492, 10.1016/j.annepidem.2004.10.009 Heinemann, 2007, Range of published estimates of venous thromboembolism incidence in young women, Contraception, 75, 328, 10.1016/j.contraception.2006.12.018 Trussell, 2008, Much ado about little: obesity, combined hormonal contraceptive use and venous thrombosis, Contraception, 77, 143, 10.1016/j.contraception.2007.11.012 Larsen, 2007, Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study, Thromb Res, 120, 505, 10.1016/j.thromres.2006.12.003 Gillum, 2000, Ischemic stroke risk with oral contraceptives: A meta-analysis, JAMA, 284, 72, 10.1001/jama.284.1.72 Khader, 2003, Oral contraceptives use and the risk of myocardial infarction: a meta-analysis, Contraception, 68, 11, 10.1016/S0010-7824(03)00073-8 Tanis, 2001, Oral contraceptives and the risk of myocardial infarction, N Engl J Med, 345, 1787, 10.1056/NEJMoa003216 Van Den Bosch, 2003, The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women, J Thromb Haemost, 1, 439, 10.1046/j.1538-7836.2003.00079.x 1975, Oral contraceptives and stroke in young women, JAMA, 231, 718, 10.1001/jama.1975.03240190022010 Croft, 1989, Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study, BMJ, 298, 165, 10.1136/bmj.298.6667.165 D'Avanzo, 1994, Oral contraceptive use and risk of myocardial infarction: an Italian case-control study, J Epidemiol Community Health, 48, 324, 10.1136/jech.48.3.324 Dunn, 1999, Risk of myocardial infarction in young female smokers, Heart, 82, 581, 10.1136/hrt.82.5.581 Hannaford, 1994, Oral contraception and stroke, Stroke, 25, 935, 10.1161/01.STR.25.5.935 Heinemann, 1998, Thromboembolic stroke in young women, Contraception, 57, 29, 10.1016/S0010-7824(97)00204-7 Kemmeren, 2002, Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke, Stroke, 33, 1202, 10.1161/01.STR.0000015345.61324.3F Lewis, 1997, The use of oral contraceptives and the occurrence of acute myocardial infarction in young women, Contraception, 56, 129, 10.1016/S0010-7824(97)00118-2 Lidegaard, 1993, Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study, BMJ, 306, 956, 10.1136/bmj.306.6883.956 Lidegaard, 1995, Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease, Br J Obstet Gynaecol, 102, 153, 10.1111/j.1471-0528.1995.tb09070.x Lubianca, 2003, Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women, Contraception, 67, 19, 10.1016/S0010-7824(02)00429-8 Narkiewicz, 1995, Ambulatory blood pressure in mild hypertensive women taking oral contraceptives, Am J Hypertens, 8, 249, 10.1016/0895-7061(95)96212-3 Siritho, 2003, Risk of ischemic stroke among users of the oral contraceptive pill: the Melbourne Risk Factor Study (MERFS) Group, Stroke, 34, 1575, 10.1161/01.STR.0000077925.16041.6B 1996, results of an international, multicentre, case-control study, Lancet, 348, 505, 10.1016/S0140-6736(95)12394-6 1996, results of an international, multicentre, case-control study, Lancet, 348, 498, 10.1016/S0140-6736(95)12393-8 1997, results of an international multicentre case-control study, Lancet, 349, 1202, 10.1016/S0140-6736(97)02358-1 Lubianca, 2005, Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension, J Hum Hypertens, 19, 451, 10.1038/sj.jhh.1001841 Cagnacci, 2009, Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study, Contraception, 80, 34, 10.1016/j.contraception.2009.01.012 Walsh, 1991, Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins, N Engl J Med, 325, 1196, 10.1056/NEJM199110243251702 Walsh, 1993, Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism, J Clin Invest, 91, 2126, 10.1172/JCI116437 Kim, 2002, Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study, Diabetes Care, 25, 1027, 10.2337/diacare.25.6.1027 Chasan-Taber, 1997, A prospective study of oral contraceptives and NIDDM among U.S. women, Diabetes Care, 20, 330, 10.2337/diacare.20.3.330 Diab, 2000, Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A, J Obstet Gynaecol Res, 26, 17, 10.1111/j.1447-0756.2000.tb01195.x Godsland IF, 1992, Insulin resistance, secretion, and metabolism in users of oral contraceptives, J Clin Endocrinol Metab, 74, 64, 10.1210/jc.74.1.64 Kasdorf G, 1988, Prospective studies of insulin sensitivity in normal women receiving oral contraceptive agents, J Clin Endocrinol Metab, 66, 846, 10.1210/jcem-66-4-846 Skouby, 1987, Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes, J Clin Endocrinol Metab, 64, 519, 10.1210/jcem-64-3-519 Gaspard, 2003, A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism, Contraception, 67, 423, 10.1016/S0010-7824(02)00537-1 Klipping, 2005, Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism, Contraception, 71, 409, 10.1016/j.contraception.2004.12.005 Ahmed, 2005, Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy, Diabetes Care, 28, 1988, 10.2337/diacare.28.8.1988 Roumen, 2007, The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials, Contraception, 75, 420, 10.1016/j.contraception.2007.01.013 Tuppurainen, 2004, The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study, Contraception, 69, 389, 10.1016/j.contraception.2004.01.004 Westhoff, 2005, Higher body weight does not affect NuvaRing's efficacy, Obstet Gynecol, 56S, 105 Burkman, 2007, Transdermal hormonal contraception: benefits and risks, Am J Obstet Gynecol, 197, 134, 10.1016/j.ajog.2007.04.027 Zieman, 2002, Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data, Fertil Steril, 77, S13, 10.1016/S0015-0282(01)03275-7 Brunner Huber, 2006, Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina, Ann Epidemiol, 16, 637, 10.1016/j.annepidem.2006.01.001 Cole, 2007, Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users, Obstet Gynecol, 109, 339, 10.1097/01.AOG.0000250968.82370.04 Simpson, 2001, Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database, BJOG, 108, 56, 10.1016/S0306-5456(00)00004-8 Westhoff, 1996, Depot medroxyprogesterone acetate contraception, J Reprod Med, 41, 401 Black, 1978, The effect of medroxyprogesterone acetate on blood pressure, Int J Gynaecol Obstet, 17, 83, 10.1002/j.1879-3479.1979.tb00121.x Taneepanichskul, 1999, Effects of DMPA on weight and blood pressure in long-term acceptors, Contraception, 59, 301, 10.1016/S0010-7824(99)00037-2 1998, Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives, Contraception, 57, 315, 10.1016/S0010-7824(98)00041-9 Lunt, 1996, Self-reported changes in capillary glucose and insulin requirements during the menstrual cycle, Diabetes Med, 13, 525, 10.1002/(SICI)1096-9136(199606)13:6<525::AID-DIA123>3.0.CO;2-D Radberg, 1982, Oral contraception in diabetic women, Horm Metab Res, 14, 61, 10.1055/s-2007-1018924 Skouby, 1986, Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles, Fertil Steril, 46, 858, 10.1016/S0015-0282(16)49825-0 Visser, 2006, Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2, Cochrane Database Syst Rev (4), 10.1002/14651858.CD003990.pub3 1998, Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception, Lancet, 352, 428, 10.1016/S0140-6736(98)05145-9 Russo, 2010, Ulipristal acetate for emergency contraception, Drugs Today (Barc), 46, 655, 10.1358/dot.2010.46.9.1516982 Glasier, 2010, Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis, Lancet, 375, 555, 10.1016/S0140-6736(10)60101-8 Schwarz, 2006, Contraceptive counseling of diabetic women of reproductive age, Obstet Gynecol, 107, 1070, 10.1097/01.AOG.0000216002.36799.b4